Review
Version 1
This version is not peer-reviewed
Zebrafish as Toxicological Model for Screening and Recapitulate Human Diseases
Maria Virginia Caballero
Version 1
: Received: 20 December 2016 / Approved: 20 December 2016 / Online: 20 December 2016 (10:34:56 CET)
How to cite: Caballero, M.V.; Candiracci, M. Zebrafish as Toxicological Model for Screening and Recapitulate Human Diseases. Preprints 2016, 2016120103 (doi: 10.20944/preprints201612.0103.v1). Caballero, M.V.; Candiracci, M. Zebrafish as Toxicological Model for Screening and Recapitulate Human Diseases. Preprints 2016, 2016120103 (doi: 10.20944/preprints201612.0103.v1).
Abstract
Embryonic and larval Danio rerio is increasingly used as a toxicological model to conduct rapid in vivo tests and developmental toxicity assays; the zebrafish features as high genetic homology to mammals; robust phenotypes; and its value in high-throughput genetic and chemical screening have made it a powerful tool to evaluate in vivo toxicity. New methodologies of genome editing as CRISPR/Cas9; ZFN or Talen make it a suitable model to perform studies to pair human genetic diseases as well. This review surveys recent studies; employing zebrafish as experimental model; comparing it with other in vivo and in vitro models; presenting zebrafish as a potent vertebrate tool to evaluate drug toxicity to facilitate more extensive; easy and comprehensive knowledge of new generation drugs.
Subject Areas
zebrafish; models; evaluation; drugs; cardiotoxicity; genotoxicity
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.
Leave a public commentSend a private comment to the author(s)